{
    "code": "02022109",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022109",
    "time": "2020-02-25 12:50:46",
    "許可證字號": "衛署藥輸字第022109號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/05\/31",
    "註銷理由": "未展延而逾期者屆期未申請展延業者重新申請查驗登記本署於0920818發證",
    "有效日期": "97\/08\/18",
    "發證日期": "92\/08\/18",
    "許可證種類": "製　劑",
    "舊證字號": "02019937",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202210901",
    "中文品名": "泰胃美注射液２００公絲／２公撮",
    "英文品名": "TAGAMET INJECTION 200MG\/2ML",
    "適應症": "住院病人伴隨有病理性胃酸分泌過高之症狀、頑固性（難治的）十二指腸潰瘍、或不能口服之病人消化性潰瘍之短期替代療法",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 2公撮安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1115901100  荷商葛蘭素史克藥廠股份有限公司臺灣分公司",
        "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640000500",
            "成分名稱": "CIMETIDINE",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}